JPY 2316.0
(-1.78%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 4.37 Billion JPY | 19.62% |
2022 | 3.13 Billion JPY | -6.63% |
2021 | 3.88 Billion JPY | 29.17% |
2020 | 3.15 Billion JPY | -9.37% |
2019 | 3.31 Billion JPY | -4.93% |
2018 | 3.47 Billion JPY | 6.71% |
2017 | 3.3 Billion JPY | -42.78% |
2016 | 2.59 Billion JPY | 1.37% |
2015 | 3.01 Billion JPY | -1.79% |
2014 | 3.08 Billion JPY | 6.79% |
2013 | 2.83 Billion JPY | 12.71% |
2012 | 2.4 Billion JPY | 10.59% |
2011 | 1.92 Billion JPY | 1.03% |
2010 | 2.01 Billion JPY | 17.39% |
2009 | 1.41 Billion JPY | -8.02% |
2008 | 735 Million JPY | -18.24% |
2007 | 2 Billion JPY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 917.25 Million JPY | -15.5% |
2024 Q2 | 1.37 Billion JPY | 49.5% |
2023 Q2 | 779.13 Million JPY | -20.42% |
2023 Q3 | 1.16 Billion JPY | 49.27% |
2023 Q4 | 1.12 Billion JPY | -3.36% |
2023 FY | - JPY | 19.62% |
2023 Q1 | 979 Million JPY | 10.13% |
2022 Q4 | 888.95 Million JPY | -9.26% |
2022 Q3 | 979.67 Million JPY | 68.1% |
2022 Q2 | 582.79 Million JPY | 25.8% |
2022 FY | - JPY | -6.63% |
2022 Q1 | 463.28 Million JPY | -52.66% |
2021 Q1 | 530.28 Million JPY | -29.82% |
2021 Q3 | 999.17 Million JPY | 41.55% |
2021 FY | - JPY | 29.17% |
2021 Q4 | 978.68 Million JPY | -2.05% |
2021 Q2 | 705.88 Million JPY | 33.11% |
2020 Q2 | 595.14 Million JPY | 110.95% |
2020 FY | - JPY | -9.37% |
2020 Q1 | 282.12 Million JPY | -59.4% |
2020 Q3 | 666.36 Million JPY | 11.97% |
2020 Q4 | 755.56 Million JPY | 13.39% |
2019 Q4 | 694.96 Million JPY | 55.76% |
2019 FY | - JPY | -4.93% |
2019 Q3 | 446.17 Million JPY | -43.75% |
2019 Q2 | 793.17 Million JPY | 22.97% |
2019 Q1 | 645.02 Million JPY | -27.02% |
2018 FY | - JPY | 6.71% |
2018 Q4 | 883.85 Million JPY | 11.19% |
2018 Q3 | 794.92 Million JPY | 36.0% |
2018 Q2 | 584.48 Million JPY | 10.7% |
2018 Q1 | 527.99 Million JPY | -32.56% |
2017 FY | - JPY | -42.78% |
2017 Q4 | 782.88 Million JPY | -4.84% |
2017 Q3 | 822.73 Million JPY | 35.62% |
2017 Q2 | 606.64 Million JPY | 34.73% |
2017 Q1 | 450.25 Million JPY | -88.66% |
2016 Q4 | 3.97 Billion JPY | 708.2% |
2016 Q2 | 486.95 Million JPY | 146.55% |
2016 Q1 | 197.5 Million JPY | -94.43% |
2016 FY | - JPY | 1.37% |
2016 Q3 | 491.36 Million JPY | 0.91% |
2015 Q3 | 563.91 Million JPY | -0.51% |
2015 Q4 | 3.54 Billion JPY | 528.32% |
2015 FY | - JPY | -1.79% |
2015 Q2 | 566.79 Million JPY | 49.16% |
2015 Q1 | 379.99 Million JPY | -89.54% |
2014 Q4 | 3.63 Billion JPY | 552.63% |
2014 FY | - JPY | 6.79% |
2014 Q1 | 334.77 Million JPY | -90.55% |
2014 Q2 | 658.86 Million JPY | 96.81% |
2014 Q3 | 556.37 Million JPY | -15.55% |
2013 Q4 | 3.54 Billion JPY | 795.16% |
2013 FY | - JPY | 12.71% |
2013 Q1 | 417.84 Million JPY | -86.34% |
2013 Q2 | 507.78 Million JPY | 21.53% |
2013 Q3 | 395.68 Million JPY | -22.08% |
2012 FY | - JPY | 10.59% |
2012 Q3 | 528.27 Million JPY | 28.28% |
2012 Q2 | 411.82 Million JPY | 100.66% |
2012 Q4 | 3.05 Billion JPY | 479.08% |
2012 Q1 | 205.23 Million JPY | -92.93% |
2011 Q1 | 250.03 Million JPY | -91.15% |
2011 Q2 | 331.31 Million JPY | 32.51% |
2011 Q3 | 237.12 Million JPY | -28.43% |
2011 Q4 | 2.9 Billion JPY | 1124.98% |
2011 FY | - JPY | 1.03% |
2010 Q1 | 351.88 Million JPY | -86.55% |
2010 Q2 | 686.84 Million JPY | 95.19% |
2010 Q4 | 2.82 Billion JPY | 535.59% |
2010 FY | - JPY | 17.39% |
2010 Q3 | 444.4 Million JPY | -35.3% |
2009 Q2 | 394.89 Million JPY | 174.75% |
2009 FY | - JPY | -8.02% |
2009 Q4 | 2.61 Billion JPY | 407.15% |
2009 Q3 | 515.82 Million JPY | 30.62% |
2009 Q1 | 143.72 Million JPY | -95.45% |
2008 Q2 | 89.87 Million JPY | 0.0% |
2008 Q3 | 217.02 Million JPY | 141.46% |
2008 Q4 | 3.16 Billion JPY | 1356.65% |
2008 FY | - JPY | -18.24% |
2007 FY | - JPY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
DVx Inc. | 807.98 Million JPY | -441.681% |
Seikagaku Corporation | 2.09 Billion JPY | -108.812% |
Eiken Chemical Co., Ltd. | 5.7 Billion JPY | 23.283% |
Create Medic Co., Ltd. | 1.39 Billion JPY | -214.555% |
PHC Holdings Corporation | 39.08 Billion JPY | 88.803% |
Techno Medica Co., Ltd. | 1.95 Billion JPY | -124.076% |
Nihon Kohden Corporation | 23.44 Billion JPY | 81.332% |
Fukuda Denshi Co., Ltd. | 36.23 Billion JPY | 87.92% |
Japan Lifeline Co., Ltd. | 12.39 Billion JPY | 64.676% |
Japan Medical Dynamic Marketing, INC. | 3.27 Billion JPY | -33.708% |
3-D Matrix, Ltd. | 2.09 Billion JPY | -109.211% |
CYBERDYNE Inc. | -2 Million JPY | 218934.7% |